These findings suggest that the genes associated with NCOR2 activation in our cell model correlate with the well-established molecular breast cancer subtypes (Perou et al, 2000) and thereby may provide prognostic information for ERα-positive breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.